Disease Detectives

0.0(0)
Studied by 0 people
call kaiCall Kai
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/351

encourage image

There's no tags or description

Looks like no tags are added yet.

352 Terms

1
New cards

primary role: control + prevention of disease in pops/groups of indv (ex: diagnosing cases associated w outbreaks + treating ppl w communicable disease ex: tuberculosis/syphilis) ⇒ activities may overlap w/ those in clinical med

Public Health Approach

2
New cards

primary role: diagnosis + treatment of illness in indvs, preventative med (ex: immunizations, smoking cessation, obesity counseling, behavior/lifestyle concerns)

Clinical Approach

3
New cards

prevention, treatment, management of illness + preservation of mental + physical well-being through services offered by medical + allied health professions

Clinical care (health care)

4
New cards

Public health problems:

infectious/chronic diseases, emergencies, injuries, environmental health problems TOP10 by CDC: alcohol-related harms, food safety, healthcare-associated infections, heart disease + stroke, HIV, motor vehicle injury, nutrition, phys activity, obesity, prescription drug overdose, teen pregnancy, tobacco use

5
New cards

study of distribution + determinants of health-related states/events in specified pops + application of this study to control of health problem Purpose in Public Health Practice: determine agent, host, env factors that affect health; determine relative importance of causes of illness, disability, death; ID those segments of pop that have greatest risk from specific causes of ill health; evaluate effectiveness of health programs + services in improving pop health

Epidemiology

6
New cards

pop oriented, studies community origins of health problems related to nutrition, env, human behavior

Classical epidemiology

7
New cards

studies patients in health care settings to improve diagnosis & treatment of diseases & prognosis for patients alr affected by a disease. Infectious disease epidemiology- heavily dependent on laboratory support. b) Chronic disease epidemiology- dependent on complex sampling & statistical methods

Clinical epidemiology

8
New cards

identifying time, place, person involved in onset of health-related events. Generate hypothesis. Intervention studies not performed.

Descriptive epidemiology

9
New cards

applied early in outbreak + captures all cases; includes many non-cases

Sensitive case definition

10
New cards

applied after outbreak is considered more well understood; will exclude most non-cases/atypical cases + likely to include only true cases

Specific case definition

11
New cards

finding causes of health-related event + ID interventions of health problem; Conduct test for hypothesis. Interventions analyzed; Have comparison group

Analytical epidemiology

12
New cards

starts at exposure in past + moves forward to outcome;

Retrospective

13
New cards

useful where exposure is rare, can calc incidence ⇒ can compute relative risk & risk diff CON of Retrospective

PRO of Retrospective

14
New cards

starts at present exposure + moves forward in time to outcome

Prospective

15
New cards

can calc incidence rates, can measure when exposure was, compared to case-control it minimizes recall bias

PRO of Prospective

16
New cards

CON of Prospective: more expensive compared to case-control

17
New cards

control certain factors w/in study from beginning; internal validity increased by doubling blinding, randomization, following specific study protocol NOT reprocessing + calibration of results; Clinical trials for indvs + community trials for communities

Experimental study

18
New cards

similar to RCT, participants are assigned to group based on non-random criteria; done for ethical reasons; proposes some sort of treatment or intervention but also observes subjects/effects + compares the current patterns with the old patterns

Quasi experiments

19
New cards

can determine causality, less expensive/time consuming than RCT (no need to randomize), tests effectiveness > efficacy, good external validity, meets requirements of causality such as: temporality, strength of association, dose response, slightly worse at causation than RCT

PRO of Quasi experiment

20
New cards

not randomized, less internal validity, overestimate effect size, selection bias, maturation bias,hawthorne effect, regression to mean, measurements tend to revert back to normal

CON

21
New cards
22
New cards

human experiment that randomly assigns participants to experimental or control group; mainly used in testing new drugs and treatments

Randomized Controlled Trial

23
New cards

least subject to bias ⇒ gold standard, used if no harmful effects; reduces selection bias and confounding

PRO of RCT

24
New cards

loss to follow up, intent to treat, randomization issues, not all exposures can be treatments

CON of RCT

25
New cards

does not control circumstances Descriptive study

Observation study

26
New cards

relies on comparisons btwn diff groups to determine role of diff causative conditions/risk factors

Analytic study

27
New cards

CON of RCT: recall bias

28
New cards

USE RELATIVE RISK; compares people with and without exposures to see what happens to each, prospective or retrospective; determine deg of association btwn various risk factors + outcomes; exposed + unexposed groups need to be similar to account for confounding factors; compare incidence in exposed group to incidence in unexposed group

Cohort study

29
New cards

Most accurate, good measure of exposure, correct time sequence, good for rare exposures, high internal validity, ez risk calc; calculate relative risk and incidence

PRO of cohort study

30
New cards

Time consuming, expensive, bad for rare diseases, possible loss of follow-up (attrition), can estimate incidence but not prevalence

CON of cohort study

31
New cards
32
New cards

USE ODDS RATIO; compares people with and without disease to find common exposures, Works backward from effect to suspected cause; Works w group of ppl w disease (case-patients) + comparison group w/o disease (control) to compare previous exposure btwn groups ⇒ see how many of them exposed to exposure); can use multiple controls of diff types; calculates odds ratio

Case Control study

33
New cards

Good for rare diseases + long latency periods, less expensive & faster, requires fewer participants

PRO of case control study

34
New cards

time-order confusion, error in recalling exposure, only 1 outcome, recall bias; cannot calculate incidence/prevalence bc you chose # of case-controls + controls which changes prevalence every time

CON of case control study

35
New cards
36
New cards

a survey, health questionaire, determines exposure + disease at single moment of time; all indv in study population asked about current disease status + current/past exposure status; exposures + health outcomes measured simultaneously. Assess presence (prevalence) of health outcome at that point of time w/o regard to duraton.

Cross Sectional study

37
New cards

fastest; least expensive; less likely to have bias due to loss of follow-up; more efficient; good for > 1 outcome

PRO of cross sectional study

38
New cards

possible time-order confusion; least confidence in findings; confounding variables, only measures prevalence, time-order confusion

CON of cross sectional study

39
New cards
40
New cards

looks for differences between groups of people with a shared characteristic rather than individuals

Ecological study

41
New cards

often 1st approach in determining if association exists b4 carrying out more expensive difficult studies

PRO of Ecological study

42
New cards

least informative bc unable to reliably estimate indv exposures; Subject to ecological fallacy= relationships identified at group level assumed true for indv; comparison of geographical locations; Ex: incidence rate of cancer among specific pop, mean level of BP of patients seen at clinic, avg sunlight exposure at specific geographic location

CON of Ecological study

43
New cards

countable in a finite amount of time (age in years, # of pregnancies)

Discrete variable

44
New cards

not countable in finite amount of time (age, height, time, temperature)

Continuous variable

45
New cards

having a random variable Deterministic: predictable

Stochastic

46
New cards

nominal (categorized), ordinal (categorized and ranked), interval (categorized, ranked and evenly spaced), ratio (categorized, ranked, evenly spaced w natural 0)

Variables

47
New cards

analysis= combine results of different studies; PICO (pop, intervention, comparison, outcome)= to formulate research q

Meta

48
New cards

limited to a particular region + consistently present but is manageable

Endemic

49
New cards

high prevalent level of infection begins early in left/affect most child pop

Holoendemic

50
New cards

occurrence of more cases of disease than expected in given area/among specific group of people over a particular period of time over wide geographic area. Factors: global warming changed environ conditions that favor propagation of agent, natural increase in susceptibility to host population, invasive species is vector for disease introduced to new area

Epidemic

51
New cards

often synonymous w/ epidemic but is more limited to specific geographic area

Outbreak

52
New cards

epidemic over v wide area (several countries/continents) + affect large proportion of pop

Pandemic

53
New cards

group of similar cases in certain area at a certain time, # may or may not be more than expected ex: cancer & birth defects (often expected # is unknown); Diff from outbreak: same as cluster except cases more than expected at this time+place

Cluster

54
New cards

disease occurs infrequently/irregularly

Sporadic

55
New cards

progression of disease process in indv over time, in absence of treatment; Exposure to/accumulation of factors sufficient for disease process to begin in susceptible host

Natural History + Spectrum of Disease

56
New cards

exposure= microorg

Infectious disease

57
New cards

exposure= factor that initiates process (asbestos fiber/ components in tobacco smoke ⇒ lung cancer)/promotes process (estrogen ⇒ endometrial cancer); After disease process triggered, pathological changes occur w/o individual being aware of them ⇒ stage of subclinical disease extending from time of exposure to onset of disease symptoms= incubation period (infectious diseases: time btwn exposure + symptom onset))/ latency period (chronic diseases; time btwn exposure + ability to transmit/onset of chronic symptoms) ⇒ asymptomatic + period may be brief as secs for hypersensitivity + toxic reactions as long as decades for chronic diseases (Incubation period for hepatitis A = as long as 7 weeks; Latency period for leukemia from survivors of atomic bomb blast in Hiroshima = 2-12 yrs,peaking at 6-7 yrs)

Cancer

58
New cards
59
New cards

Up: recurrence of symptoms or onset of more severe symptoms.

​Flare

60
New cards

disease that resists treatment. Progressive disease

Refractory disease

61
New cards

harmless derivative of toxin that promotes immune response.

Toxoid

62
New cards

of pathogens begin increasing/immune system begins reacting; characterized by early symptoms that might indicate disease onset before specific symptoms occur; symptoms may be non-specific.

Prodromal period

63
New cards

no fever

Nonfebrile

64
New cards

fever.

Febrile

65
New cards

active replication of pathogen/#’s peak exponentially often in short period of time; symptoms pronounced.

Acute Period

66
New cards

of pathogen begins decreasing, signs of illness decline; susceptible to developing secondary infections b/c immune systems weakened by primary.

Decline Period

67
New cards

patient recovers gradually and returns to normal, but may continue to be a source of infection even if feeling better.

Convalescent period

68
New cards

ability of virus to remain dormant in host/no replication (ex: Epstein-Barr virus, Varicella Zoster)

Viral latency

69
New cards

time btwn onset of primary case & onset of 2ndary case

Serial Interval

70
New cards

1) person, place, time 2) external agent, vector/fomite that transmits disease, susceptible host for disease (Chain of Transmission Triad= agent/Host/Environment Triad) Agent (microbial org w ability to cause disease) leaves reservoir (place where agents can thrive + reproduce) through portal of exit (place of exit providing way for agent to leave reservoir, most common: skin, GI/respiratory tract) ⇒ conveyed by some mode of transmission (method of transfer of disease-causing microorgs from one env to another) ⇒ enters appropriate portal of entry (opening that allows microorg to enter host, most common: mucous membrane of respiratory tract) to infect susceptible host (person/living org that can be infected by infectious agent under natural conditions, multiplying ⇒ resulting in infection; most vulnerable: young, elderly, ppl w/ weakened immune systems), Host factor- intrinsic factor (age, race, sex, behaviors) which influences indv’s exposure, susceptibility, response to causative agent;

2 Types of Epidemiological Triads

71
New cards

agent multiplies/grows in vector (mosquito/tick borne disease), physical, chemical, mechanical (agent transported via the outsides of vector’s body parts)- agent doesn’t undergo biological transformation in vector (fly picks up agent + deposits on open wound) Infectivity

biological

72
New cards

capacity to cause disease in host; proportion of persons infected, after exposure to a causative agent, who then develop clinical disease Virulence

Pathogenicity

73
New cards

an or in which parasite reaches adult stage/reproduces; final host (Trypanosomes

Definitive Hosts

74
New cards

organism that harbors sexually immature parasite/required by parasite to undergo dev/complete life cycle - often vector of parasite to reach definitive host (Flukes, Taenia Solium or Pork tapeworm, Malaria)

Secondary/Intermediate Host

75
New cards

org harboring sexually immature parasite/not necessary for parasite’s development cycle to progress – “dumps” for non-mature stages of a parasite

Paratenic/Transport Host

76
New cards

org that typically doesn’y allow transmission to definitive host → prevents parasite from completing its development (West Nile Disease/Toxoplasmosis/Sarcocystosis) Reservoir Host

Dead-End/incidental/accidental Host

77
New cards

living carrier that carries agent from reservoir to susceptible host (ex: mosquito transmits malaria protozoans, insects, arthropods, dogs, bats; lice) (DIRECT transmission)

Vector

78
New cards

human spread disease after period of illness believing they’re cured

Convalescent

79
New cards

one transmits pathogens immediately following infection but before developing symptoms

Incubatory

80
New cards

one transmits a disease for a long period of time

Chronic

81
New cards

inherited a disease trait but shows no symptoms

Genetic

82
New cards

one who transmits an infectious disease for a short amount of time

Transient/temporary

83
New cards

vectors (ex: ticks/mosquitoes) that carry pathogens that multiply w/in their bodies/transmission via bite

Biological Vector

84
New cards

vector (ex: filth flies) picks up pathogen on outside of its body/transmits via physical contact (shigellosis, typhoid

Mechanical Vector

85
New cards

inanimate obj that carries agent from reservoir to susceptible host (ex: water, food, air) (DIRECT transmission)

Vehicle

86
New cards

inanimate obj that facilitate indirect transmission of infectious agent (ex: comb infested w head lice, dust particles containing infectious cold virus that remain after droplets of infected saliva coughed in air) (INDIRECT transmission)

Fomite

87
New cards

infectious disease transmissible from animals to humans

Zoonosis

88
New cards

contaminated food ingested, allow vector to introduce agent into host (ex: mosquito bite), air that allow agent to be inhaled by host/agents spread by contact btwn 2 ppl

Envs that bring agent + host together

89
New cards
90
New cards

physical contact, skin-to-skin contact, kissing, sex (mononucleosis + gonorrhea); prevent by wearing gloves + masks

Direct/contact Transmission: Direct Contact

91
New cards

from a reservoir via fomites; contact w/ soil with hookworm; prevent by avoiding contact with fomites + avoiding contact of hands with mucous membranes

Indirect Contact

92
New cards

large, short-range aerosols (up to 1m after exiting mouth) produced by coughing, sneezing (pertussis + meningococcal infection)

Droplet Transmission

93
New cards

agent carried to locations by a substance/non-living object

Indirect/vehicle Transmission

94
New cards

occurs via droplets (typically mucous droplets) that liquids that remain airborne as aerosols (very small droplets) or associated with dust particles (measles)

Airborne Transmission

95
New cards

pathogens found in food + not killed during processing may be transmitted via food product

Food-borne Transmission

96
New cards

fecal contaminated water, gastrointestinal pathogens present in feces (not likely to spread)

Water-borne Transmission

97
New cards

insects transport pathogen, agent carried to other locations by a living org

Vector Transmission

98
New cards

person who doesn’t appear to be infected but still capable of transmitting disease

Carrier

99
New cards

carriers able to spread pathogens after infection, prior to showing symptoms during incubation period

Incubatory

100
New cards

carriers able to spread pathogens after recovery

Convalescent carriers